AYTU Aytu BioPharma
Aytu BioPharma earnings company data as of 4:47 AM ET 10/22
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 12 Nov | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q4 | 22 Sep | EPS | -0.35 | — | — |
| Rev | $12.3M | $6.6M | Miss -46.2% |
Insider trades
Open-market buys and sales by AYTU's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- None no sales outside a trading plan
- None no planned (10b5-1) sales
No open-market buys or sales on file.
Also filed in the last 12 months, not counted as buying or selling: 8 stock grants.
SEC filings
Recent issuer filings from EDGAR, 24 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| DEF 14A | FORM DEF 14A | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | FORM 10-K | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 1.02 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | FORM 10-Q | Filing Doc | |
| 8-K | 1.01,2.02,3.02,3.03,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | FORM 10-Q | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | FORM 10-Q | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| DEF 14A | FORM DEF 14A | Filing Doc | |
| DEFA14A | FORM DEFA14A | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | FORM 10-K | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.